PURCHASE AND COLLABORATION AGREEMENT by and among COLUMBIA LABORATORIES, INC., COVENTRY ACQUISITION, INC. and WATSON PHARMACEUTICALS, INC. Dated as of March 3, 2010Purchase and Collaboration Agreement • March 5th, 2010 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 5th, 2010 Company Industry JurisdictionTHIS PURCHASE AND COLLABORATION AGREEMENT (this “Agreement”), dated as of March 3, 2010 (the “Execution Date”), is entered into by and among Columbia Laboratories, Inc., a Delaware corporation (“Seller”), Watson Pharmaceuticals, Inc., a Nevada corporation (“Parent”) (solely for purposes of Section 11.2 herein) and Coventry Acquisition, Inc., a Delaware corporation and wholly-owned Subsidiary of Parent (“Buyer”). Each of Seller and Buyer is sometimes referred to herein, individually, as a “Party” and, collectively, as the “Parties.”
PURCHASE AND COLLABORATION AGREEMENT by and among COLUMBIA LABORATORIES, INC., COVENTRY ACQUISITION, INC. and WATSON PHARMACEUTICALS, INC. Dated as of March 3, 2010Purchase and Collaboration Agreement • March 4th, 2010 • Columbia Laboratories Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 4th, 2010 Company Industry JurisdictionTHIS PURCHASE AND COLLABORATION AGREEMENT (this “Agreement”), dated as of March 3, 2010 (the “Execution Date”), is entered into by and among Columbia Laboratories, Inc., a Delaware corporation (“Seller”), Watson Pharmaceuticals, Inc., a Nevada corporation (“Parent”) (solely for purposes of Section 11.2 herein) and Coventry Acquisition, Inc., a Delaware corporation and wholly-owned Subsidiary of Parent (“Buyer”). Each of Seller and Buyer is sometimes referred to herein, individually, as a “Party” and, collectively, as the “Parties.”